Telehealth stories

Aug 10, 2026

Hims & Hers posts wider loss as shift to branded weight-loss drugs drives up costs

Hims & Hers Health reported a wider-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs, sending shares down 6% in extended trading. The company plans to enter the peptides market before year-end.

Aug 10, 20263 sources

May 15, 2026

Supreme Court Preserves Mail Access to Abortion Pill Mifepristone While Lawsuit Continues

The U.S. Supreme Court on Thursday maintained access to the abortion pill mifepristone through telehealth and mail delivery, setting aside lower court restrictions while litigation over the drug continues. Mifepristone is used in more than 60% of U.S. abortions.

May 15, 20264 sources